Thousands of people throughout the UK are experiencing a enigmatic and incapacitating skin disorder that has confounded medical professionals. Sufferers describe their skin as becoming badly inflamed, cracked and flaking, commonly affecting large areas of their body, yet many doctors struggle to diagnose or treat the condition. The phenomenon, referred to as topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social media, with videos documenting patients’ experiences receiving more than a billion views on TikTok alone. Despite affecting a rising number of people, TSW remains so poorly understood that some general practitioners and dermatologists question whether it exists at all. Now, in a first-of-its-kind move, researchers across the UK are commencing a major study to determine what is causing these unexplainable symptoms and how some people come to develop the condition whereas others do not.
The Mysterious Illness Sweeping Across the UK
Bethany Gamble’s story exemplifies the devastating impact of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had controlled her eczema well with steroid creams since childhood, but at eighteen, her condition took a dramatic turn for the worse. Her skin became intensely inflamed and red, breaking and leaking whilst the itching became what she refers to as “bone deep”. Within two years, the pain had become so severe that she was unable to leave her bed, requiring round-the-clock care from her mother. Most distressing of all, Bethany experienced repeated dismissal by medical professionals who attributed her symptoms to standard eczema and continued prescribing the very treatments she believed were causing her suffering.
The medical establishment remains divided on how to address TSW, with deep divisions about its basic nature. Some experts regard it as a severe allergic response to the steroid creams that form the first-line treatment for eczema across the NHS. Others maintain it amounts to a serious exacerbation of current skin conditions rather than a distinct syndrome, whilst a handful remain unconvinced of its reality. This professional uncertainty has placed patients like Bethany stuck in a diagnostic uncertainty, struggling to access appropriate treatment. The failure to reach consensus has led Professor Sara Brown at the University of Edinburgh to create the inaugural major UK research project examining TSW, funded by the National Eczema Society.
- Symptoms comprise significant swelling, skin fissuring and intense itching throughout the body
- Patients report “elephant skin” hardening and extreme shedding of dead skin cells
- Medical professionals commonly disregard TSW as standard eczema or refuse to acknowledge it
- The condition can be so debilitating that sufferers become unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Mild Eczema to Disabling Symptoms
For many patients, withdrawal from topical steroids constitutes a severe decline from a formerly stable dermatological condition. What begins as intermittent itching in skin creases can quickly progress into a full-body inflammatory response that renders patients unable to function. The change typically happens suddenly, without warning, converting a controllable long-term condition into an severe medical emergency. People describe their skin turning impossibly hot, red and inflamed, with significant cracking and weeping that demands constant attention. The bodily burden is worsened by fatigue, as the persistent itching disrupts sleep and healing, establishing a destructive cycle of deterioration.
The pace at which TSW progresses catches many sufferers off guard. Those who have dealt with eczema for years, sometimes decades, find themselves unprepared for the magnitude of symptoms that develop when their condition rapidly deteriorates. Everyday tasks become formidable obstacles: showering becomes unbearable, dressing requires assistance, and maintaining personal hygiene demands substantial energy. Some patients describe feeling as though their skin is being attacked from within, with inflammation spreading across their body in patterns that bear little resemblance to their previous eczema flare-ups. This dramatic transformation often prompts sufferers to seek urgent medical help, only to encounter disbelief from healthcare professionals.
The Quest for Recognition
Perhaps the cruelest aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients presenting with severe, unexplained symptoms are routinely told they merely suffer from eczema flaring up, despite their insistence that this is essentially distinct from anything they’ve encountered previously. Doctors frequently react by prescribing stronger steroids or higher dosages, potentially worsening the very condition patients believe the creams caused. This pattern of rejection leaves sufferers feeling abandoned by the healthcare system, compelled to manage their illness alone whilst being informed that their personal experience lacks validity. Many patients report experiencing repeated invalidation, their worries disregarded as emotional or psychological in nature rather than actual physical health issues.
The absence of professional agreement has established a significant divide between patient experience and clinical acknowledgement. Without clear diagnostic criteria or defined treatment approaches, GPs and dermatologists find it difficult to diagnose TSW or offer appropriate support. Some clinicians remain completely sceptical the condition exists, treating all severe presentations as typical eczema or other known dermatological conditions. This professional uncertainty translates into delayed diagnosis, unsuitable therapies and significant emotional suffering for people experiencing physical symptoms. The growing visibility of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to examine the experiences reported by vast numbers of individuals, even as the healthcare profession remains divided on how to respond.
- Signs may develop abruptly in people with previously stable eczema managed by topical steroids
- Patients frequently encounter scepticism from medical practitioners who ascribe deterioration to typical eczema exacerbations
- Medical professionals remain divided on whether TSW is a genuine condition or severe eczema exacerbation
- Lack of established diagnostic standards means numerous patients struggle to access suitable care and support
- Online platforms has amplified patient voices, with TSW hashtags accumulating over a billion views globally
Ethnic Inequalities in Assessment and Clinical Management
The diagnostic challenges surrounding topical steroid withdrawal become increasingly evident amongst people with darker skin tones, where symptoms can be significantly harder to identify visually. Redness and inflammation, the characteristic indicators of TSW in those with lighter complexions, manifest differently across different ethnic groups, yet many assessment protocols remain based around how the condition appears in white patients. This difference means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW commonly experience substantially longer periods in recognition and validation. Clinical practitioners trained mainly through presentations in lighter skin may fail to recognise the typical indicators, causing additional diagnostic errors and unsuitable therapeutic suggestions that can exacerbate suffering.
Research into TSW has historically overlooked the lived experiences with deeper skin tones, perpetuating a cycle where their symptoms remain insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been largely shaped by voices with lighter skin, potentially skewing medical understanding and public awareness. As Professor Sara Brown’s groundbreaking UK study progresses, ensuring diverse representation amongst research participants will be essential to developing truly inclusive diagnostic frameworks and therapeutic strategies. Without intentional action to prioritise the perspectives of diverse populations, treatment inequalities in TSW identification and care risk widening further, leaving vulnerable populations without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Treatment and Research Approaches Emerging
Leading UK Investigation Currently Happening
Professor Sara Brown’s pioneering research at the Edinburgh University constitutes a watershed moment for TSW sufferers pursuing validation and comprehension. Funded by the National Eczema Society, the study has recruited numerous participants across the UK to investigate the biological mechanisms driving topical steroid withdrawal. By analysing symptoms, saliva samples and skin biopsies, researchers hope to identify why some people experience TSW whilst others using identical steroid regimens do not. This rigorous investigation marks a significant shift from dismissal to serious investigation.
The study team collaborating with Dr Alice Burleigh from patient advocacy group Scratch That, brings both medical knowledge and personal experience to the research. Their joint methodology recognises that patients themselves hold essential understanding into their medical conditions. Professor Brown has noted patterns in TSW that defy explanation by conventional eczema understanding, including marked “elephant skin” thickening, severe shedding and distinctly marked areas of inflammation. The research findings could significantly transform how doctors manage diagnosis and treatment of this serious condition.
Available Treatments and Their Limitations
At present, management options for TSW are quite limited and often unsatisfactory. Many healthcare professionals persist in prescribing topical steroids despite clear evidence indicating they could worsen symptoms in vulnerable patients. Some patients note transient relief from moisturisers, antihistamines and systemic drugs, though outcomes differ significantly. Dermatologists continue to disagree on most effective management plans, with some advocating complete steroid cessation whilst others advocate phased withdrawal. This absence of agreement leaves patients navigating their treatment journeys largely alone, depending significantly on peer support networks and digital communities for advice.
Psychological support and specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including dietary modifications, managing environmental factors and whole-person treatment approaches, though scientific evidence supporting these interventions remains sparse. The absence of established clinical protocols means treatment decisions frequently rely upon individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research yields conclusive findings, TSW sufferers frequently describe experiencing abandonment by conventional medicine.
- Emollient creams and hydrating products to enhance skin barrier function and reduce water loss
- Antihistamines to control pruritus and related sleep disruption during flare-ups
- Oral corticosteroids or immune-suppressing agents for serious presentations under specialist supervision
- Therapeutic counselling to tackle trauma and anxiety related to prolonged skin suffering
Testimonies of Aspiration and Perseverance
Despite the lack of clarity surrounding TSW and the frequently dismissive perspectives from healthcare professionals, patients are gaining resilience in shared community and collective experience. Digital support communities have emerged as lifelines for those contending with the disorder, offering practical guidance and validation when traditional medicine has failed them. Many individuals affected recount the point at which they found the TSW hashtag as transformative—finally connecting with others with identical symptoms and recognising they were not alone in their suffering. This collective voice has been powerful enough to trigger the initial serious research initiatives, showing that patient-led campaigns can drive medical progress even when institutional structures remain sceptical.
Bethany Gamble and people in similar situations are determined to raise awareness and push for proper recognition of TSW within the medical establishment. Their readiness to recount personal stories of their challenges on online platforms has encouraged open dialogue around a disorder that various medical professionals still are unwilling to accept. These patients are not waiting passively for answers; they are actively participating in clinical trials, tracking their signs meticulously, and requiring that their testimonies be treated with respect. Their fortitude in the confronting ongoing pain and medical gaslighting offers hope that responses might prove to be within attainment, and that upcoming sufferers will obtain the acknowledgement and treatment they urgently require.
- Patient-led research initiatives are addressing shortcomings overlooked by traditional medical institutions and advancing knowledge of TSW
- Digital support networks offer emotional support, practical coping strategies, and peer validation for affected individuals worldwide
- Campaign work are gradually shifting medical perception, prompting dermatologists to examine rather than overlook individual accounts
